Monoclonal Antibodies

Basiliximab

Products Basiliximab is commercially available as an injectable (Simulect, Novartis). It has been approved in many countries, in the EU, and in the United States since 1998. Structure and properties Basiliximab is a chimeric monoclonal human murine IgG1κ antibody with a molecular mass of 144 kDa. It is produced by biotechnological methods. The drug name … Basiliximab

Ustekinumab

Products Ustekinumab is commercially available as a solution for injection (Stelara). It was newly approved in the EU in January 2009, in the United States in September 2009, and in many countries in October 2010. In 2017, a concentrate for the preparation of an infusion solution was also approved. This article refers to subcutaneous administration. … Ustekinumab